The Montreal Definition and Classification of Gastroesophageal Reflux Disease: A Global Evidence-Based Consensus
2006/08/01 by Nimish Vakil, Sander Veldhuyzen van Zanten, Sander V. van Zanten +5 · 29 citations
Medicine · #Gastroesophageal reflux and treatments #Esophageal Cancer Research and Treatment #Bariatric Surgery and Outcomes
paper · doi:10.1111/j.1572-0241.2006.00630.x
Abstract
OBJECTIVES: A globally acceptable definition and classification of gastroesophageal reflux disease (GERD) is desirable for research and clinical practice. The aim of this initiative was to develop a consensus definition and classification that would be useful for patients, physicians, and regulatory agencies. METHODS: A modified Delphi process was employed to reach consensus using repeated iterative voting. A series of statements was developed by a working group of five experts after a systematic review of the literature in three databases (Embase, Cochrane trials register, Medline). Over a period of 2 yr, the statements were developed, modified, and approved through four rounds of voting. The voting group consisted of 44 experts from 18 countries. The final vote was conducted on a 6-point scale and consensus was defined a priori as agreement by two-thirds of the participants. RESULTS: The level of agreement strengthened throughout the process with two-thirds of the participants agreeing with 86%, 88%, 94%, and 100% of statements at each vote, respectively. At the final vote, 94% of the final 51 statements were approved by 90% of the Consensus Group, and 90% of statements were accepted with strong agreement or minor reservation. GERD was defined as a condition that develops when the reflux of stomach contents causes troublesome symptoms and/or complications. The disease was subclassified into esophageal and extraesophageal syndromes. Novel aspects of the new definition include a patient-centered approach that is independent of endoscopic findings, subclassification of the disease into discrete syndromes, and the recognition of laryngitis, cough, asthma, and dental erosions as possible GERD syndromes. It also proposes a new definition for suspected and proven Barrett's esophagus. CONCLUSIONS: Evidence-based global consensus definitions are possible despite differences in terminology and language, prevalence, and manifestations of the disease in different countries. A global consensus definition for GERD may simplify disease management, allow collaborative research, and make studies more generalizable, assisting patients, physicians, and regulatory agencies.
Cited by
- Phase III, randomised, double-blind, multicentre study to evaluate the efficacy and safety of vonoprazan compared with lansoprazole in Asian patients with erosive oesophagitis
- Pathophysiology of Gastroesophageal Reflux Disease
- Association between sleep bruxism and gastroesophageal reflux disease
- Gastroenterology [wikipedia]
- Alarm symptoms in early diagnosis of cancer in primary care: cohort study using General Practice Research Database. [europepmc]
- Reliability and validity of the Gastrointestinal Symptom Rating Scale (GSRS) and Quality of Life in Reflux and Dyspepsia (QOLRAD) questionnaire in dyspepsia: a six-country study. [europepmc]
- Clinical practice. Gastroesophageal reflux disease. [europepmc]
- History, molecular mechanisms, and endoscopic treatment of Barrett's esophagus. [europepmc]
- Barrett's oesophagus and oesophageal adenocarcinoma: time for a new synthesis. [europepmc]
- American Gastroenterological Association technical review on the management of Barrett's esophagus. [europepmc]
- Consensus statements for management of Barrett's dysplasia and early-stage esophageal adenocarcinoma, based on a Delphi process. [europepmc]
- Prediction of Barrett's esophagus among men. [europepmc]
- Update on the epidemiology of gastro-oesophageal reflux disease: a systematic review. [europepmc]
- Lifestyle Intervention in Gastroesophageal Reflux Disease. [europepmc]
- Using the modified Delphi method to establish clinical consensus for the diagnosis and treatment of patients with rotator cuff pathology. [europepmc]
- Effective and safe proton pump inhibitor therapy in acid-related diseases - A position paper addressing benefits and potential harms of acid suppression. [europepmc]
- Presentation and Epidemiology of Gastroesophageal Reflux Disease. [europepmc]
- Modern diagnosis of GERD: the Lyon Consensus. [europepmc]
- Pediatric Gastroesophageal Reflux Clinical Practice Guidelines: Joint Recommendations of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the European Society for Pediatric Gastroenterology, Hepatology, and Nutrition. [europepmc]
- Updated International Consensus Diagnostic Criteria for Eosinophilic Esophagitis: Proceedings of the AGREE Conference. [europepmc]
- Gastrointestinal Tract Disorders in Older Age. [europepmc]
- Phase III, randomised, double-blind, multicentre study to evaluate the efficacy and safety of vonoprazan compared with lansoprazole in Asian patients with erosive oesophagitis. [europepmc]
- Prevalence of Gastroesophageal Reflux Disease and Proton Pump Inhibitor-Refractory Symptoms. [europepmc]
- Global Prevalence and Risk Factors of Gastro-oesophageal Reflux Disease (GORD): Systematic Review with Meta-analysis. [europepmc]
- ACG Clinical Guidelines: Clinical Use of Esophageal Physiologic Testing. [europepmc]
- GWAS of peptic ulcer disease implicates Helicobacter pylori infection, other gastrointestinal disorders and depression. [europepmc]
- Multitrait genetic association analysis identifies 50 new risk loci for gastro-oesophageal reflux, seven new loci for Barrett's oesophagus and provides insights into clinical heterogeneity in reflux diagnosis. [europepmc]
- AGA Clinical Practice Update on the Personalized Approach to the Evaluation and Management of GERD: Expert Review. [europepmc]
- Updates to the modern diagnosis of GERD: Lyon consensus 2.0. [europepmc]
Related